XML 30 R16.htm IDEA: XBRL DOCUMENT
v3.24.2

Accrued Expenses and Other Current Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2023
Payables and Accruals [Abstract] |
Accrued Expenses and Other Current Liabilities | 8. Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following:
|  | December 31, |
|  | 2023 |  |  | 2022 |
Accrued clinical trial expense |  | $ | 189 |  |  | $ | 2,659 |
Accrued professional fees |  |  | 573 |  |  |  | 880 |
Accrued wages, bonuses, commissions and vacation |  |  | 3,011 |  |  |  | 2,576 |
Accruals for construction in progress |  |  | 214 |  |  |  | 322 |
Accrued compliance fee |  |  | 1,145 |  |  |  | — |
Other |  |  | 2,448 |  |  |  | 2,632 |
|  | $ | 7,580 |  |  | $ | 9,069 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration